Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1993-02-25
1994-05-31
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Lymphokine
424 93R, 424 93T, 4352351, 435236, 435237, 435238, A61K 3912, A61K 3923
Patent
active
053167643
ABSTRACT:
The present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12 week old pups, and even to immunize the majority of pups at the age of 6 weeks in the presence of maternally derived antibodies.
REFERENCES:
patent: 4303645 (1981-12-01), Carmichael et al.
patent: 4810494 (1989-03-01), Welsh
Wilson et al., Vet Q., 4(3): 108-116 (1982).
O'Brien et al., J. Am. Vet. Med. Assoc., 188(7): 699-701 (1986).
"A Research Update: Canine Parvovirus", Ralston-Purina Co. (1980).
Appel, "Canine Parvovirus Infection" Cornell Research Laboratory for Diseases of Dogs, Laboratory Report, Series 3, No. 1 (Mar. 1979).
Akzo N.V.
Blackstone William M.
Scheiner Toni R.
Schneller John W.
LandOfFree
Canine Parvovirus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine Parvovirus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine Parvovirus vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1626529